The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunityChristina K. Baumgartner, Joshua H. Decker, Hakimeh Ebrahimi-Nik et al.|Nature|2023Cited by 170
The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancerJ.E. Berchuck, Love Goyal, Francesco Facchinetti et al.|Annals of Oncology|2022Cited by 138
Mutant IDH1 inhibition induces dsDNA sensing to activate tumor immunityMeng‐Ju Wu, Nabeel Bardeesy, Hiroshi Kondo et al.|Science|2024Cited by 87
SULT1A1-dependent sulfonation of alkylators is a lineage-dependent vulnerability of liver cancersLei Shi, Nabeel Bardeesy, Phuong Vu et al.|Nature Cancer|2023Cited by 24
DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer through Impaired SIK Signaling and CRTC2/p300-Mediated Transcriptional ReprogrammingIlaria Gritti, Nabeel Bardeesy, Jinkai Wan et al.|Cancer Discovery|2024Cited by 14